06938.HK
Suzhou Ribo Life Science Co
HKSE · Healthcare · Biotechnology · CN
HKD 41.84
−2.70%Next report
Analyst consensus
- Next report date
- Mar 25, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 27, 2026
- EPS actual
- HKD 0.02
- EPS estimate
- —
- Revenue actual
- HKD 61.8M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 27, 2026 | — | HKD 0.02 | — | HKD 61.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 25, 2027